Skip to main content
WAVERLEY PHARMA INC. logo

WAVERLEY PHARMA INC. — Investor Relations & Filings

Ticker · WAVE ISIN · CA94357L1058 LEI · 254900VT8CXPPV1G5Q51 TSXV Manufacturing
Open in API
Filings indexed 110 across all filing types
Latest filing 2020-08-25 Regulatory Filings
Country CA Canada
Listing TSXV WAVE

About WAVERLEY PHARMA INC.

https://www.waverleypharma.com/

Waverley Pharma Inc. is a specialty biopharmaceutical company engaged in the research, development, and commercialization of safe, effective, and affordable therapeutics. The company primarily focuses on oncology, developing treatments such as poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer. Waverley Pharma commercializes its pharmaceutical products in markets including the United Kingdom, evidenced by successful tenders for drugs like Capecitabine with NHS Scotland. Furthermore, the company operates a retail pharmacy in the United States, integrating pharmaceutical innovation with direct patient service operations.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Waverley Pharma's subsidiary has been granted marketing authorization for two pharmaceutical products in Spain and Italy. It contains no financial statements, no regulatory filings, no management or board changes, no voting results, no earnings data, and no detailed financial or operational reports. It is a straightforward announcement about regulatory approval for products, which does not fit into any of the specific financial or corporate filing categories such as Annual Report, Earnings Release, or Management Reports. It is also not a report publication announcement or certification. Given the nature of the content, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-08-25 English
Interim MD&A - English.pdf
Regulatory Filings
2020-08-24 English
Interim financial statements/report – English.pdf
Regulatory Filings
2020-08-24 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings for a venture issuer, signed by the CEO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2020. The text explicitly states it is a certification and does not contain the actual interim financial data or analysis itself. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS). The document length is short (3004 characters), and it is a certification rather than the interim report itself.
2020-08-24 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CFO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2020. It is a certification letter rather than the interim report itself. The document explicitly states it is a certification and does not contain actual financial data or substantive financial analysis. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself. The document length is short (3003 characters), consistent with a certification letter rather than a full report.
2020-08-24 English
Management information circular - English.pdf
Regulatory Filings
2020-06-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.